Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

DBV Technologies (DBV)

Paris
Currency in EUR
0.81
+0.07(+9.46%)
Closed
DBV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
0.750.90
52 wk Range
0.512.07
Key Statistics
Edit
Prev. Close
0.81
Open
0.75
Day's Range
0.75-0.9
52 wk Range
0.51-2.07
Volume
2.16M
Average Volume (3m)
399.77K
1-Year Change
-42.31%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DBV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2.46
Upside
+203.70%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

DBV Technologies Company Profile

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

Employees
105
Market
France

Compare DBV to Peers and Sector

Metrics to compare
DBV
Peers
Sector
Relationship
P/E Ratio
−0.8x−1.8x−0.7x
PEG Ratio
−1.190.290.00
Price/Book
1.5x2.9x2.6x
Price / LTM Sales
6.6x6.9x3.2x
Upside (Analyst Target)
232.4%56.3%46.4%
Fair Value Upside
Unlock−0.2%6.9%Unlock

Analysts' Recommendations

1 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2.46

(+203.70% Upside)

People Also Watch

0.4950
ATOS
-32.65%
160.02
AIRP
+0.30%
2.59
ELIOR
+2.78%
24.42
STMPA
-0.85%
11.70
UBIP
+1.04%

FAQ

What Is the DBV Technologies (DBV) Premarket Price Today?

The DBV Technologies (DBV) premarket price is . Premarket price change units: . Premarket percentage change: . Premarket volume: . Current date: 04 Dec 2024. Previous close: 0.81

What Stock Exchange Does DBV Technologies Trade On?

DBV Technologies is listed and trades on the Paris stock exchange.

What Is the Stock Symbol for DBV Technologies?

The stock symbol for DBV Technologies is "DBV."

What Is the DBV Technologies Market Cap?

As of today, DBV Technologies market cap is 78.55M.

What is DBV Technologies Earnings Per Share?

The DBV Technologies EPS is -1.06.

What Is the Next DBV Technologies Earnings Date?

DBV Technologies will release its next earnings report on 05 Mar 2025.

From a Technical Analysis Perspective, Is DBV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Is DBV Technologies (DBV) Price Target According to Analysts?

Based on analysts, the average 12-month price target for DBV Technologies is , with a high estimate of and a low estimate of . analysts recommend buying the stock, while suggest selling, leading to an overall rating of . The stock has an upside potential of %.

What Is DBV Technologies (DBV) Price Target According to Analysts?

Based on analysts, the average 12-month price target for DBV Technologies is , with a high estimate of and a low estimate of . analysts recommend buying the stock, while suggest selling, leading to an overall rating of . The stock has an upside potential of %.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.